Schering adds compliance exec
Executive Summary
Former Lilly Chief Compliance Officer Lori Queisser takes over as Schering-Plough's Senior-VP Global Compliance & Business Practices starting Feb. 20. Schering's current compliance chief Brent Saunders is being promoted to Senior VP & President-Consumer Health Care effective June 1, where he will lead Schering's U.S. and Canadian consumer unit. Saunders joined the firm in November 2003 to serve in the then newly-created compliance position (1"The Pink Sheet" Oct. 13, 2003, p. 17). Schering is nearing completion of a compliance-related consent decree from 2002. Both Saunders and Queisser will report to CEO Fred Hassan...
You may also be interested in...
Schering GMPs: Over 25% Of Consent Decree Steps Complete, Company Says
Schering-Plough is over a quarter of the way through fulfilling its requirements under a 2002 consent decree
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.